X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (887) 887
Publication (178) 178
Book Review (5) 5
Book Chapter (4) 4
Newspaper Article (3) 3
Dissertation (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (603) 603
index medicus (519) 519
epha2 (356) 356
receptor, epha2 - metabolism (342) 342
animals (322) 322
oncology (281) 281
cell line, tumor (239) 239
mice (224) 224
cancer (223) 223
female (220) 220
receptor, epha2 - genetics (219) 219
expression (205) 205
male (177) 177
receptor tyrosine kinase (172) 172
epha2 protein (157) 157
activation (154) 154
biochemistry & molecular biology (152) 152
cell biology (148) 148
ligands (148) 148
signal transduction (140) 140
phosphorylation (137) 137
article (132) 132
kinases (132) 132
proteins (130) 130
gene expression (116) 116
tyrosine kinase (112) 112
research (110) 110
metastasis (105) 105
angiogenesis (102) 102
overexpression (101) 101
tyrosine (99) 99
in-vivo (97) 97
receptor (93) 93
cells (86) 86
immunohistochemistry (86) 86
ephrin-a1 - metabolism (82) 82
middle aged (81) 81
epha2 receptor (77) 77
research article (75) 75
receptors (74) 74
cell proliferation (72) 72
protein binding (72) 72
aged (70) 70
medicine (69) 69
receptor, epha2 - chemistry (69) 69
multidisciplinary sciences (68) 68
analysis (67) 67
gene expression regulation, neoplastic (66) 66
physiological aspects (66) 66
prognosis (66) 66
ephrins (65) 65
genetic aspects (64) 64
tumors (64) 64
protein (63) 63
adult (62) 62
growth-factor (62) 62
survival (61) 61
apoptosis (60) 60
cell line (59) 59
growth (59) 59
protein-tyrosine kinase (59) 59
receptor, epha2 - antagonists & inhibitors (59) 59
carcinoma (58) 58
gene (58) 58
invasion (58) 58
ligand (58) 58
receptor, epha2 - biosynthesis (57) 57
e-cadherin (56) 56
amino acid sequence (55) 55
molecular sequence data (55) 55
binding (54) 54
biology (53) 53
mice, nude (53) 53
breast cancer (52) 52
medicine, research & experimental (52) 52
migration (52) 52
breast-cancer (51) 51
health aspects (51) 51
blotting, western (49) 49
mutation (49) 49
pharmacology & pharmacy (49) 49
science (49) 49
tumorigenesis (49) 49
family (47) 47
inhibition (46) 46
receptor, epha2 (46) 46
genetics & heredity (45) 45
ephrin-a1 - genetics (44) 44
cells, cultured (43) 43
cell adhesion & migration (42) 42
up-regulation (42) 42
down-regulation (41) 41
melanoma (41) 41
tumor cells, cultured (41) 41
cell movement (40) 40
development and progression (40) 40
eph receptors (40) 40
receptor, epha2 - immunology (40) 40
therapy (40) 40
xenograft model antitumor assays (40) 40
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 05/2011, Volume 17, Issue 5, pp. 589 - 595
Hepatitis C virus (HCV) is a major cause of liver disease, but therapeutic options are limited and there are no prevention strategies. Viral entry is the first... 
MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | B TYPE-I | NEUTRALIZING ANTIBODIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE | FACTOR RECEPTOR | CELL BIOLOGY | EPIDERMAL-GROWTH-FACTOR | CELL TRANSMISSION | HUMAN LIVER | INFECTION | ERLOTINIB | Erlotinib Hydrochloride | RNA, Small Interfering - genetics | Receptor, Epidermal Growth Factor - genetics | Hepatitis C - therapy | Humans | Virus Internalization - drug effects | RNA Interference | Membrane Proteins - physiology | Base Sequence | Hepacivirus - physiology | Hepatitis C - prevention & control | Receptor, Epidermal Growth Factor - physiology | Hepacivirus - drug effects | Cell Line | Antiviral Agents - pharmacology | Receptor, EphA2 - physiology | Tetraspanin 28 | Claudin-1 | Animals | Hepatitis C - virology | Receptor, EphA2 - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Antigens, CD - physiology | Hepatitis C - physiopathology | Ligands | Mice | Protein Kinase Inhibitors - pharmacology | Receptor, EphA2 - antagonists & inhibitors | Quinazolines - pharmacology | Host-Pathogen Interactions - physiology | Ephrin A | Antiviral agents | Care and treatment | Patient outcomes | Physiological aspects | Research | Hepatitis C | Hepatitis | Viruses | Drug therapy | Antiviral drugs | Receptor, EphA2 | Hépatology and Gastroenterology | Antigens, CD81 | Antiviral Agents | Quinazolines | Virus Internalization | Membrane Proteins | Host-Pathogen Interactions | Life Sciences | Human health and pathology | Protein Kinase Inhibitors | RNA, Small Interfering | Hepacivirus | Antigens, CD | Receptor, Epidermal Growth Factor | Liver | HCV escape variants | Cell-cell transmission | genetics | pharmacology | Antiviral | therapy | physiology | drug effects | prevention & control | antagonists & inhibitors | physiopathology | Phosphotyrosine kinase | virology
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2011, Volume 6, Issue 9, p. e24426
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2010, Volume 107, Issue 24, pp. 10860 - 10865
Journal Article
Journal Article
Journal Article
Cancer Discovery, ISSN 2159-8274, 11/2013, Volume 3, Issue 11, pp. 1302 - 1315
Journal Article